Social networks
4,040Activities
Entity types
Location
Campus-Vienna-Biocenter 5, 1030 Wien, Austria
Wien
Austria
Employees
Scale: 11-50
Estimated: 11
Engaged corporates
0Added in Motherbase
1 year, 3 months agoImproving the lives of patients with next generation therapies for cancer and respiratory disease, including COVID-19.
APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies.
Our company has a well balanced portfolio with one product on the market and several promising products from clinical to pre-clinical stages. As for the product on the market, APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients. We out-licensed Qarziba® globally to EUSA Pharma Ltd, for which it holds exclusive rights to this product.
APEIRON’s key projects and technologies are bolstered by a strong patent portfolio with broad territorial coverage. Our development expertise is validated through partnerships with leading global pharmaceutical companies and academic institutions.
Oncology, Immunomodulation, Biologics, and Respiratory